<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref114">
 <mixed-citation publication-type="journal" id="cit114">
  <name>
   <surname>Shah</surname>
   <given-names>P. P.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Kaletsky</surname>
   <given-names>R. L.</given-names>
  </name>; 
  <name>
   <surname>Myers</surname>
   <given-names>M. C.</given-names>
  </name>; 
  <name>
   <surname>Purvis</surname>
   <given-names>J. E.</given-names>
  </name>; 
  <name>
   <surname>Jing</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Huryn</surname>
   <given-names>D. M.</given-names>
  </name>; 
  <name>
   <surname>Greenbaum</surname>
   <given-names>D. C.</given-names>
  </name>; 
  <name>
   <surname>Smith</surname>
   <given-names>A. B.</given-names>
  </name>; 
  <name>
   <surname>Bates</surname>
   <given-names>P.</given-names>
  </name>; 
  <name>
   <surname>Diamond</surname>
   <given-names>S. L.</given-names>
  </name>
  <article-title>A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells</article-title>. 
  <source>Mol. Pharmacol.</source>
  <year>2010</year>, 
  <volume>78</volume>, 
  <fpage>319</fpage>â€“
  <lpage>324</lpage>. 
  <pub-id pub-id-type="doi">10.1124/mol.110.064261</pub-id>.
  <pub-id pub-id-type="pmid">20466822</pub-id>
 </mixed-citation>
</ref>
